Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Convalescent Plasma Therapy Market’s CAGR Through 2034?

The market size for convalescent plasma therapy has seen a quick expansion in the last few years, elevating from $0.05 billion in 2024 and predicted to reach $0.06 billion in 2025, witnessing a compound annual growth rate (CAGR) of 11.4%. Factors such as pandemics and widespread diseases, advancements in immunotherapy research, the authorization of emergency use, patient accessibility along with an increase in awareness among clinicians and public have significantly contributed to the history period growth.

It is projected that the convalescent plasma therapy market will experience fast-paced growth in the upcoming years, with an anticipated value of $0.09 billion by 2029, at a compound annual growth rate (CAGR) of 13.7%. The predicted growth during this period is potentially due to emerging pathogens, development of immunotherapies, regulatory structures, global readiness, and public health projects. Significant trends expected during this forecasting period are standardization of collection and processing, focus on specific plasma components, tailor-made treatments, the usage of telemedicine and remote monitoring, and research into the long-term impacts.

Which Primary Drivers Are Supporting the Continued Expansion of the Convalescent Plasma Therapy Market?

The growth of the convalescent plasma therapy market could be propelled by the superior efficiency and safety assessed during trials for COVID-19 Convalescent Plasma Therapy (CPT) within the forecast period. This form of transfusion has historically been used in treating various infectious disease outbreaks like SARS‐1, Middle East Respiratory Syndrome (MERS), and the 2009 H1N1. A study undertaken by the Houston Methodist hospital in June 2022, aimed at assessing the safety and efficacy of COVID-19 convalescent plasma therapy, confirmed the procedure’s safety and absence of adverse events, as well as its efficiency, with a recovery rate of 76%. In May 2020, another study in the Journal of Medical Virology reported potential reduced mortality rates in severely ill patients, observable positive effects on clinical symptoms, increased neutralizing antibody titers, and disappearance of SARS‐CoV‐2 RNA following convalescent plasma therapy. The therapy’s safety and efficiency when handling COVID-19 cases will likely stimulate global growth in the convalescent plasma therapy market.

Explore Comprehensive Insights Into The Global Convalescent Plasma Therapy Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What Are the Leading Industry Players Dominating the Convalescent Plasma Therapy Market?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

What Are the Latest Trends Leading to Disruption in the Convalescent Plasma Therapy Market?

The advancement of antibody-driven immunotherapy for potential use in treating COVID-19 presents significant potential for the convalescent plasma therapy market. Convalescent plasma therapy uses antibodies created in response to the coronavirus by a donor to enhance the immune response of the recipient. Companies are initiating trials, forming partnerships and investing in antibody-driven COVID-19 treatment. In August 2023, US-based biotech firm Regeneron Pharmaceuticals Inc. began a collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to support the clinical development, manufacturing, and licensing processes for a next-generation COVID-19 monoclonal antibody therapy aimed at preventing SARS-CoV-2 infection. This collaboration forms part of Project NextGen, a venture by the U.S. Department of Health and Human Services (HHS) to develop a stream of innovative COVID-19 vaccines and treatments. In line with the project’s framework, Regeneron will independently design and propose an antibody candidate, which BARDA and Regeneron will evaluate and choose for further research, production, and regulatory efforts. The market growth is anticipated to be propelled by the focus on antibody-driven COVID-19 therapy, as convalescent plasma therapy employs antibodies.

Secure Your Global Convalescent Plasma Therapy Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Are the Major Segments of the Convalescent Plasma Therapy Market and Their Role in Driving Growth?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products

Which Regions Are Significant to the Growth of the Convalescent Plasma Therapy Market?

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Convalescent Plasma Therapy Market Classified and Defined in Market Analysis?

Convalescent plasma is plasma that has been collected from people who have recovered or are convalescing and contains antibodies against the infection-causing microorganism. It is used for the treatment of patients infected by the respective pathogen.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Radiotherapy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Cold Plasma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: